|
Federal Register
Notices
> Notice of Registration - 2009
>
AMRI Rensselaer, Inc.
FR Doc E9-21527[Federal Register: September 8, 2009 (Volume 74, Number 172)]
[Notices] [Page 46234-46235] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08se09-118]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 17, 2009, and published in the Federal Register on
April 29, 2009, (74 FR 19598), AMRI Rensselaer, Inc., 33 Riverside Avenue,
Rensselaer, New York 12144, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
[[Page 46235]]
|
Drug
|
Schedule
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Lisdexamfetamine (1205)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Meperidine (9230)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage form) (9273)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture bulk controlled substances for use in
product development and for distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of AMRI Rensselaer,
Inc. to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated AMRI
Renssealaer Inc. to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and testing of
the company's physical security systems, verification of the company's
compliance with State and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk manufacturer
of the basic classes of controlled substances listed.
Dated: August 21, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-21527 Filed 9-4-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|